New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors
Two Groups Take Different Approaches To Toxicity Of Saltz Regimen In Studies
Zevalin Regimen Better Than Rituximab Alone For NHL
SWOG Trial Reports Longest Survival To Date For NSCLC
Two Drugs Slow Progress Of Metastatic Prostate Cancer
New Ultrasound Technique For Hard To Diagnose Cysts
NCI-Approved Clinical Trials Listed For May 2001
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored









